CTLA4 and COVID-19: Thus CD4 + and CD8 + T cells in severe COVID-19 patients presented with concomitant over-expressions of co-inhibitory molecules PD-1, PD-L1, CTLA-4 and TIM-3 in accordance with the development of a state of T exhaustion after severe SARS-Co-V2 infection.